Novel and Structurally Diversified Bacterial DNA Gyrase Inhibitors Discovered through a Fluorescence-Based High-Throughput Screening Assay
Citations Over TimeTop 14% of 2022 papers
Abstract
Bacterial DNA gyrase, a type IIA DNA topoisomerase that plays an essential role in bacterial DNA replication and transcription, is a clinically validated target for discovering and developing new antibiotics. In this article, based on a supercoiling-dependent fluorescence quenching (SDFQ) method, we developed a high-throughput screening (HTS) assay to identify inhibitors targeting bacterial DNA gyrase and screened the National Institutes of Health's Molecular Libraries Small Molecule Repository library containing 370,620 compounds in which 2891 potential gyrase inhibitors have been identified. According to these screening results, we acquired 235 compounds to analyze their inhibition activities against bacterial DNA gyrase using gel- and SDFQ-based DNA gyrase inhibition assays and discovered 155 new bacterial DNA gyrase inhibitors with a wide structural diversity. Several of them have potent antibacterial activities. These newly discovered gyrase inhibitors include several DNA gyrase poisons that stabilize the gyrase-DNA cleavage complexes and provide new chemical scaffolds for the design and synthesis of bacterial DNA gyrase inhibitors that may be used to combat multidrug-resistant bacterial pathogens. Additionally, this HTS assay can be applied to screen inhibitors against other DNA topoisomerases.
Related Papers
- → Plasmid DNA Supercoiling by DNA Gyrase(2003)4 cited
- → Escherichia coli DNA Topoisomerase I Mutants Have Compensatory Mutations at or near DNA Gyrase Genes(1983)10 cited
- The role of supercoiling in altering chromosome structure, gene expression and antibiotic resistance in bacteria(2017)
- → [Structural insight into negative DNA supercoiling by DNA gyrase, a bacterial type 2A DNA topoisomerase].(2014)
- → Gyrase ☆(2016)